BioSpace News Archive

Policy

J&J Increases Prices As More Bills Are Filed in Congress to Lower Drug Costs

As the Democratic-led House of Representatives begin to file a number of bills aimed at lowering the cost of prescription drugs in the United States, Johnson & Johnson has joined the ranks of pharma companies that started out the new year with a price hike.

January 11, 2019
·
2 min read
·
Alex Keown
Business

Neoleukin Therapeutics Hopes to Improve on Nature’s Approach to Battling Cancer

Seattle-based Neoleukin Therapeutics spun out of the University of Washington Medicine’s Institute for Protein Design’s research with the help of CoMotion, a collaborative innovation hub.

January 11, 2019
·
2 min read
·
Mark Terry
Business

Amidst Restructuring and Executives Changes, AstraZeneca Lays off 210 in Colorado

AstraZeneca has indicated it plans to lay off 210 people in Boulder and Longmont. The reason is the company is consolidating “the biologics manufacturing network in one large-scale drug substance facility” in Frederick, Maryland.

January 11, 2019
·
3 min read
·
Mark Terry
Policy

Pharma Feels Impact of Government Shutdown as FDA Drug Review Work Slows

As the partial government shutdown enters its 21st day, tying it for the longest U.S. shutdown in history, the impact is becoming more and more realized within the pharmaceutical industry.

January 11, 2019
·
2 min read
·
Alex Keown
Policy

Are Scare Tactics Being Used to Avoid Biosimilar Competition?

According to U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb, less than two percent of Americans use biologics, but they account for 40 percent of total spending on prescription drugs.

January 11, 2019
·
4 min read
·
Mark Terry
Business

Billions of Dollars This Week Show AI Is in BioPharma’s Present and Future

As 2019 gets underway for the biopharma industry, more companies are increasing their reliance on the use of artificial intelligence as part of their drug discovery process.

January 11, 2019
·
3 min read
·
Alex Keown
FDA

FDA Action Alert: Exelixis and Immunomedics

Because of the government shutdown, which as of Monday, January 14 is into its fourth week, 40 percent of the U.S. FDA employees were furloughed. However, the two approvals described here should still be on track.

January 11, 2019
·
3 min read
·
Mark Terry
Career Advice

What Makes Life Sciences Professionals Happy at Work

Why are some people enthusiastic about going to work in the morning, while others are miserable? Is it the person or is it the job? Many people haven’t stopped to consider if they might be contributing to their own unhappiness at work.

January 11, 2019
·
4 min read
·
Porschia Parker
Deals

Johnson & Johnson Recommends Rejection Of Below-Market “Mini-Tender” Offer By Peer & Peri LLC

Johnson & Johnson received notice of an unsolicited “mini-tender” offer by Peer & Peri LLC (Peer & Peri) to purchase up to 30,000 shares of common stock of Johnson & Johnson, representing approximately 0.001% of the company’s outstanding shares.

January 11, 2019
·
3 min read
Job Trends

CES 2019 Proves AI and 5G Will Transform the Future

Every company is a tech company at the world’s most influential tech event

January 11, 2019
·
5 min read